YOKNEAM, Israel, Sept. 10,
2024 /PRNewswire/ -- InMode Ltd.
(Nasdaq: INMD), a leading global provider of
innovative medical technologies, today announced that its Board of
Directors has approved a share repurchase program of up to 7.68
million ordinary shares.
"Following the completion of our share buyback program announced
earlier this year, the board's authorization to enact this new
share repurchase program demonstrates our ongoing confidence in the
long-term outlook of the company," commented Moshe Mizrahy, InMode's Chief Executive
Officer.
"InMode continues to be profitable and generate cash, even
during challenging macro economic conditions," noted Yair Malca, InMode's Chief Financial Officer.
"Based on discussions with tax advisors, the company believes that
there will be no tax implications as a result of the existing
program. Our strong cash position and the current low valuation
triggered the decision of the board to authorize another buyback
plan shortly after the previous one ended."
The Company's ordinary share repurchases, if any, will be funded
with available cash. Share repurchases may be commenced, suspended
or discontinued at any time.
About InMode
InMode is a leading global provider of innovative medical
technologies. InMode develops, manufactures, and markets devices
harnessing novel radiofrequency ("RF") technology. InMode strives
to enable new emerging surgical procedures as well as improve
existing treatments. InMode has leveraged its medically accepted
minimally-invasive RF technologies to offer a comprehensive line of
products across several categories for plastic surgery, gynecology,
dermatology, otolaryngology, and ophthalmology. For more
information about InMode and its wide array of medical
technologies, visit www.inmodemd.com.
Forward-Looking Statements
The information in this press release includes forward-looking
statements within the meaning of the federal securities laws. These
statements generally relate to future events or InMode's future
financial or operating performance. Actual outcomes and
results may differ materially from what is expressed or forecast in
such forward-looking statements. In some cases, you can identify
these statements because they contain words such as "anticipate,"
"believe," "estimate," "expect," "intend," "may," "plan,"
"predict," "project," "will," "would" and similar expressions that
concern our expectations, strategic plans or intentions.
Forward-looking statements are based on management's current
expectations and assumptions, and are subject to inherent
uncertainties, risks and changes in circumstances that are
difficult to predict. Consequently, actual results could differ
materially from those indicated in these forward-looking
statements. When considering these forward-looking statements, you
should keep in mind the risk factors and other cautionary
statements included in InMode's Annual Report on Form 20-F filed
with the Securities and Exchange Commission on February 13, 2024, and our future public filings.
InMode undertakes no obligation and does not intend to update these
forward-looking statements to reflect events or circumstances
occurring after this press release. You are cautioned not to place
undue reliance on these forward-looking statements, which pertain
only as of the date of this press release.
Company
Contact:
Yair Malca
Chief Financial
Officer
Phone: (949)
305-0108
Email:
Yair.Malca@inmodemd.com
|
Investor Relations
Contact:
Miri Segal
MS-IR LLC
Phone: (917)
607-8654
Email:
ir@inmodemd.com
|
Logo -
https://mma.prnewswire.com/media/1064477/4900205/InMode_Logo.jpg
View original content to download
multimedia:https://www.prnewswire.com/news-releases/inmode-announces-share-repurchase-program-of-up-to-7-68-million-shares-302242315.html
SOURCE InMode LTD